In France, electronic cigarettes have been highly successful, particularly for those who want to quit smoking. However, despite research showing that it poses only 5% of the harm to health compared to traditional cigarettes, it is facing threats in France.
I am a Vaper" is an online media outlet created by OneShotMedia that is fully dedicated to promoting electronic cigarettes. Its primary goal is to educate the public, especially long-term smokers who find it difficult to quit, about the many advantages of using e-cigarettes as a means of cessation.
The information contained in this resource comprises a diverse range of vocabulary related to VAPE practices, practical advice on selecting material and getting started, as well as scientific articles including those on plant glycerin. Many professionals worldwide have conducted extensive research and have concluded that VAPE is 95% less harmful to health compared to traditional cigarettes.
Could a smoking cessation product with 95% less harm than traditional cigarettes be a dream? Despite this possibility, VAPE is still facing condemnation in France and around the world. Some have voiced skepticism towards this practice, emphasizing its lack of foresight or its potential to encourage young people to take up smoking and use it as a gateway to smoking. All of these arguments remain unproven, contradicting scientific research results on the advantages of electronic cigarettes, which have been the result of hard work by great scientific and medical professionals.
The electronic cigarette is now under threat in France and Europe, with the possibility of losing the flavorings in e-cigarette oils and being subject to taxation. Supporters of e-cigarettes are clearly concerned about the tightening of the Tobacco Products Directive (TPD), which seeks to regulate e-cigarette products as tobacco products.
The media outlet "Je suis VAPEUR" has suggested that consumers and professionals seeking to support e-cigarettes in France should seek help from elected officials who may not be well-informed on the issue. To make this process easier, the media has created a "Mobilization" section on their website where visitors can send pre-written or personalized messages to their district's representatives in order to raise awareness.
It should not be forgotten that today, electronic cigarettes have become a focal point in Europe. It would be regretful if there wasn't an estimated smoking cessation tool that could save as many as 45,000 lives every year.
As pointed out by the Federation Addiction, three out of ten people in France smoke, a figure that remains higher than most neighboring European countries. Additionally, 75,000 people still die each year as a result of smoking, making it a leading cause of preventable death. There is now a greater need than ever before for mobilization.
Statement:
This article is compiled from third-party information and is intended solely for industry-related sharing and learning.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of its content. The compilation of this article is only for communication and research within the industry.
Due to limitations in the level of translation skills, the translated article may not fully reflect the original text. Please refer to the original text for accuracy.
2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, and foreign matters.
The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
